Hot Sale for Gemcitabine HCl - Naltrexone Hydrochloride CAS 16676-29-2 API USP Standard High Purity – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

, , ,

Hot Sale for Gemcitabine HCl - Naltrexone Hydrochloride CAS 16676-29-2 API USP Standard High Purity – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Chemical Name: Naltrexone Hydrochloride
Synonyms: Naltrexone HCl
CAS: 16676-29-2
API High Quality, Commercial Production

Chemical Name	Naltrexone Hydrochloride
Synonyms	Naltrexone HCl
CAS Number	16676-29-2
CAT Number	RF-API47
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C20H24ClNO4
Molecular Weight	377.86
Brand	Ruifu Chemical

Item	Specifications
Appearance	White or Almost White Crystalline Hygroscopic Powder
Infrared Absorption	Conform
Chlorides	Positive
Appearance of Solution	Clear
Acidity or Alkalinity	No more than 0.2ml of NaOH 0.02M or HCL 0.02M
Specific Rotation	-187° ~ -195° (calculated in the anhydrous basis)
Moisture (K.F)	≤10.0%
Sulfated Ashes	≤0.10%
Assay	98.0%~102.0% (on anhydrous and solvent-free basis)
Related Substances	By Liquid Chromatography
Impurity A	≤0.10%
Impurity B	≤0.10%
Impurity C	≤0.20%
Impurity D	≤0.20%
Each Other Impurity	≤0.10%
Total of Impurities	≤1.0%
Heavy Metals	≤10ppm
Residual Solvents Methanol	≤ 2000ppm
Residual Solvents Acetone	≤ 1000ppm
Test Standard	United States Pharmacopeia (USP) Standard
Usage	Active Pharmaceutical Ingredient (API)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Naltrexone Hydrochloride (CAS: 16676-29-2), a non-selective opioid receptor antagonist; congener of naloxone. Naltrexone Hydrochloride (CAS: 16676-29-2) is a potent, long-acting, orally-effective narcotic antagonist useful in the management of narcotic addiction. Naltrexone hydrochloride is a pharmacodynamic blocker of exogenous opioids. Naltrexone hydrochloride was developed by DuPont in the United States and used in gradient detoxification programs to reduce the relapse rate of opiate-dependent patients after successful detoxification. Naltrexone hydrochloride is a new kind of morphine antagonist, which is used to treat opioid dependence and has obvious deaddiction effect. It plays an important role in the adjuvant therapy of preventing relapse of opioid dependence after deaddiction. Clinically, Naltrexone is mainly used to prevent opioid addicts from relapse after detoxification. It has the characteristics of effective oral administration, long acting time and no obvious toxic and side effects. In addition, naltrexone has been reported as an experimental clinical treatment for diseases related to the endogenous opioid system, such as alzheimer’s disease, pediatric autism, alcohol dependence, chronic lung disease and obesity. Naltrexone hydrochloride is used in the treatment of alcohol and utilized for deceasing drinking habit. It is also used to prevent euphorigenic effects in the treatment of patients addicted to opioids.

Product detail pictures: